CVS Health Stock Surges After Mixed Quarterly Report

CVS Health Corp (NYSE:CVS) stock is 12% higher at $61.96 at last glance, after the pharmacy giant reported a mixed third quarter. Higher medical costs impacted net income, with adjusted earnings of$1.09 per share falling short of the $1.44 per share consensus estimate, but revenue of$95.43 billion was well above the $92.72 billion forecast. This was the company's first earnings report with newly appointed CEO David Joyner.In addition to the top- and bottom-line results, CVS Health cut its full-year profit ...